CTRI/2023/07/055921尚未招募不适用
Utility of (1–3)-β-D Glucan (BDG) in the management of invasive fungal diseases in critical care unit
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 330
- 试验地点
- 1
- 主要终点
- Assess the impact of BDG in therapeutic decision making
研究概览
简要总结
patient admitted in critical care unit above 18 years of age for whom Beta-D-Glucan test has been ordered will be included in the study. following which, data will be collected in two ways, one set demographic details & microbiological laboratory data will be collected by the principal investigator, and the other set data from the physician who is ordering the BDG test. patient followed up until their ICU stay.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 99.00 Year(s)（—）
- 性别
- All
入选标准
- •Above 18 years of age who are admitted in critical acre unit for whom BDG test ahs been ordered.
排除标准
- •No specific exclusion criteria.
结局指标
主要结局
Assess the impact of BDG in therapeutic decision making
时间窗: 1 year
次要结局
- 1.To know the indication for ordering BDG assay.   
- 2. To enumerate the host factors for acquiring IFD. (1 year)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Evaluation of (1->3)-Beta-D-Glucan as a Diagnostic Tool for HIV associated Pneumocystis PneumoniaJPRN-UMIN000014818ational Center for Global Health and Medicine180
尚未招募
Unknown
Clinical evaluation study of Beta-glucan assayinvasive fungal infectionsJPRN-UMIN000050121Osaka Metropolitan University900
Unknown
不适用
Dosage of Plasma 1, 3-β-D-glucan for the Diagnosis of Candidemia.Infection, FungalNCT03674359Assistance Publique - Hôpitaux de Paris2,000
招募中
不适用
Feasibility of Using the "CGM GUARDIAN 2" Interstitial Fluid Glucose Measurement System in Intensive Care MedicineShock, SepticHypotensionHyperglycemiaNCT04910841Centre Hospitalier Universitaire de Nice55
已完成
不适用
Degludec Insulin Use in Critically Ill PatientsDiabetes MellitusCritical IllnessHyperglycemiaNCT06056167King Faisal Specialist Hospital & Research Center155